Akanksha IVF Centre Janakpuri Launches India’s First Emotional Fertility Coaching Program
IVF today isn’t just science — it’s an emotional journey. At Akanksha IVF Centre, Janakpuri, we’re transforming the IVF experience through India’s first integrated Emotional Fertility Coaching program.
Why Emotional Coaching Matters in IVF
The road to parenthood through IVF can be filled with stress, anxiety, and emotional exhaustion. Most fertility clinics in India overlook this vital aspect — but we don’t.
How Stress Impacts IVF Success
Studies show that unmanaged emotional stress can lower the success rate of fertility treatments. IVF is not just a medical process — it’s a deeply personal and emotional experience.
Common Emotional Challenges During IVF
Performance anxiety and fear of failure
Shame or guilt associated with infertility
Relationship strain between partners
Depression and isolation
What Makes Our Emotional Fertility Program Unique?
Integrated Mind-Body Approach
Our certified fertility coaches and therapists work closely with medical professionals to provide complete care to every patient.
Key Features of Our Program
On-site emotional fertility coaching
Guided meditations, journaling, and stress-relief workshops
Support groups and community sharing
Couples therapy to improve intimacy and communication
Pre-conception mental readiness sessions
Setting a New Standard in Fertility Care in India
At Akanksha IVF Centre, we’re not just offering emotional support — we’ve made it a non-optional part of your IVF treatment plan. Because emotional health is not extra. It’s essential.
Our Philosophy: Conscious, Compassionate, and Complete Care
We’re redefining what it means to care. By supporting you emotionally, we’re helping you not just become a parent, but a stronger, healthier version of yourself.
Expert Spotlight: Dr. Poonam Nayar at Aspire 2025, Singapore
Leading the Way in Online Fertility Counseling
Dr. Poonam Nayar, Senior Psychologist at Akanksha IVF, recently delivered a powerful session on “Online Counseling for Couples Undergoing ART” at the prestigious Aspire 2025 Conference in Singapore.
Her presentation highlighted the increasing importance of psychological support for couples navigating IVF and ART.
Her work continues to put Akanksha IVF at the forefront of integrated fertility care in India.
Creating Families with Heart and Hope
At Akanksha IVF Centre, we go beyond outcomes — we build emotional strength, clarity, and deep connection. Because your journey to parenthood deserves both medical excellence and human understanding.
Akanksha IVF Centre Janakpuri: India’s First IVF Clinic with Emotional Fertility Coaching
Can Stress Cause Infertility?
Infertility is a growing concern for many couples trying to conceive, and one question that frequently arises is whether stress can impact fertility. While stress alone may not be the sole cause of infertility, scientific research suggests that chronic stress can negatively affect reproductive health in both men and women.
How Stress Affects Female Fertility
1. Hormonal Imbalance
When a woman is under constant stress, her body releases high levels of cortisol and adrenaline, which can disrupt the delicate balance of reproductive hormones such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones are crucial for ovulation, and any imbalance can lead to irregular cycles or anovulation (lack of ovulation).
2. Irregular Menstrual Cycles
Chronic stress can interfere with the hypothalamus-pituitary-ovarian (HPO) axis, leading to delayed or missed periods. This makes it difficult to predict ovulation, reducing the chances of conception.
3. Impact on the Uterus
High stress levels may lead to reduced blood flow to the uterus, which can affect the uterine lining’s ability to support implantation, increasing the risk of early pregnancy loss.
4. Emotional Factors
The anxiety of trying to conceive itself can create a vicious cycle, making it even harder for couples to get pregnant. Worrying about fertility can lead to increased stress, further disrupting reproductive health.
How Stress Affects Male Fertility
1. Reduced Sperm Quality
Studies show that men who experience high levels of chronic stress tend to have lower sperm count, decreased motility, and higher levels of abnormal sperm morphology. This directly impacts fertility and the ability to conceive.
2. Lower Testosterone Levels
Stress is linked to increased production of cortisol, which suppresses testosterone levels. Low testosterone can lead to reduced libido and erectile dysfunction, further complicating fertility.
3. Unhealthy Coping Mechanisms
Many men under stress resort to unhealthy habits such as smoking, excessive alcohol consumption, poor diet, and lack of exercise, all of which negatively impact sperm production and overall reproductive health.
Can Reducing Stress Improve Fertility?
Managing stress effectively can have a positive impact on fertility. Here are some proven strategies:
Practice Mindfulness & Meditation
Helps lower cortisol and maintain hormonal balance.
Regular Exercise
Improves circulation, reduces stress, and supports reproductive function.
Balanced Diet
Eating nutrient-rich foods supports hormonal balance and overall reproductive health.
Quality Sleep
Ensuring 7-8 hours of restful sleep helps hormonal regulation and reduces stress-related complications.
Professional Help
Therapy or counseling can help manage emotional stress related to infertility, especially for couples undergoing IVF or ART.
Final Thoughts
While stress alone may not directly cause infertility, it can significantly influence reproductive health and make conception more difficult. By managing stress effectively, individuals and couples can create a healthier environment for fertility and increase their chances of a successful pregnancy.
Can Stress Cause Infertility? | Akanksha IVF Centre Janakpuri
Present Position: Dr. KD Nayar
Presently Chief Consultant Infertility & IVF at Akanksha IVF Centre,since July 2001 in Mata Chanan Devi Hospital, a 225 bedded Superspeciality hospital in South West Delhi. Akanksha IVF Centre was established by me to provide comprehensive facilities for Assisted Reproductive Techniques of International quality control standards, performing about 600 to 700 IVF/ICSI cycles annually.
Indian Fertility Society Guideline On Poor Ovarian Response-2024
Awards
ASRM Star Award 2020, 2021, 2022, 2023 & 2024
TAPISAR Lifetime achievement AWARD-Nov.2022
FOGSI Achiever Award –April 2023
IMA Janak puri Lifetime achievement award –July 2023
ISAR Lifetime achievement award – Feb. 2024
ISSRF Lifetime achievement award – Feb. 2025
Papers & Posters Presentations
ASRM
Year
Place
Title
October 23rd-25th 2006.
ASRM, New Orleans, USA
POSTER “Comparative study of various semen preparation techniques in IUI and their effect on pregnancy”.
October 13th – 17th 2007.
Washington
POSTER “Sperm cryosurvival using minimal semen volume in test vial”.
November. 8th – 12th 2008.
San Francisco, USA
Round Table interactive session on “Aromatase inhibitors for enhancing outcome of ART”.
November. 8th – 12th 2008.
San Francisco, USA
Published: Clomiphene citrate vs. Low dose recombinant FSH for ovarian stimulation in Intra Uterine Insemination cycles for unexplained and male infertility.
October 17th – 21st 2009.
Atlanta, USA
Round Table interactive session on “Fertility Treatment of PCOS”.
October 25th – 27th 2010.
Denver, USA
POSTER “A Newer approach for ovarian stimulation in poor responders undergoing
IVF”.
October 15th – 19th, 2011.
Orlando, USA
POSTER(1)“Does pelvic tuberculosis affect the ovarian reserve and the oocyte in patients undergoing IVF”.
POSTER (2) “Is AFC a better markers then AMH & FSH in predicting the number of oocytes retrieved in women undergoing ovarian stimulation for IVF”.
October14th- 17th 2013.
Boston, USA
POSTER (1) “Choosing the right ovulation trigger in Antagonist cycle for an OHSS free clinic
POSTER (2) “Impact of Endometrial injury on successful outcome in IVF cycle”.
October 18th – 22nd2014.
Honolulu Hawaii, USA
ORAL:“Does Exogenous LH supplementation improve reproductive outcome in poor responder woman undergoing IVF/ICSI in GnRH Antagonist Protocol”.
October 17th– 21st 2015.
Baltimore, USA
POSTER “Scheduling Hysteroscopic endometrial Biopsy in Endometrial preparation cycles just preceding ET V/S any time in last one year – Does it changes Reproductive outcome.
October 16th – 20th
2016.
Salt Lake City, USA
POSTER(1) “ Affect of GnRH agonist trigger followed by low dose hCG on reproductive outcome in at risk OHSS”.
POSTER(2) “Dysregulated infertility-related genes in women with endometriosis”.
October 28th – 1st November 2017
San Antonio, Texas, USA
POSTER (1) Elective frozen Vs. Fresh Embryo transfer in Antagonist cycles in normo-responders: a randomised study.
POSTER (2) Dysregulated gene involved in implantation failure in women with endometriosis.
POSTER (3) Yoga affects IVF outcomes ?
October 6th – 10th 2018
Denver, Colorado
USA
ORAL “Adjuvant Recombinant LH (rLH) or Growth Hormone (GH) to the Antagonist protocol in poor responders undergoning IVF”
POSTER “ Is time lapse a better option to improve clinical outcome over standard incubator – A case control study”
October 13th – 16th 2019
Philadelphia, Pennsylvania, USA
POSTER “ Assessment of psychological distress in polycystic ovarian syndrome infertile patients at a tertiary level infertility care centre in India”.
October 17th – 21th 2020
Portland, Oregon, USA
POSTER (1) Does controlled ovarian hyperstimulation response varies with PCOS phenotypes: A prospective cohort study at a tertiary infertility centre in INDIA.
POSTER(2) Impact of endometriosis on anxiety, depression and quality of life and its association with pregnancy outcomes in infertile patients at a tertiary level infertility centre in INDIA.
October 17th – 20th 2021
Baltimore, Maryland, USA
POSTER (1) Single step or sequential media in embryo culture: outcome in donor oocyte cycles
POSTER (2) Comparison of microfluidic sperm sorting (MFSS) versus physiological intracytoplasmic sperm injection (PICSI) versus density gradient in high DNA fragmentation index sperm samples. POSTER (3)Transdermal oestradiol gel vs oral oestrogen for successful clinical outcome in hormone replacement Frozen embryo transfer (hr-FET) cycles- a prospective randomized controlled study. POSTER (4)Does dual trigger with combination of gonadotropin-releasing hormone agonist and low dose human chorionic gonadotropin improves clinical outcomes in normal responders in GnRH antagonist IVF- ICSI cycles.
October 24th – 26th 2022
Anaheim,CA, USA
POSTER (1) Progesterone primed ovarian stimulation protocol (PPOS) vs GnRh antagonist for patients of freeze all cycles: a prospective randomised controlled trial.
October 14th – 18th 2023
New Orleans, Louisiana, USA
“ORAL”
(1) Impact of psychosocial support with meditation on IVF/ICSI clinical outcomes: a prospective cohort study.
(2) Intramural fibroid in infertile women – Experience and Evidence.
October 20th – 23rd 2024
Denver, USA
PG Course no. 13
(1) Alternative Stimulation Protocols in Assisted Reproductive Technology.
(2) Complications and Risks in Ovarian Stimulation. Poster P 322
EFFECTIVENESS OF AUTOLOGOUS PLATELETRICH PLASMA (PRP) THERAPY FOR IMPROVING
ENDOMETRIAL THICKNESS AND PREGNANCY
OUTCOMES IN WOMEN WITH THIN
ENDOMETRIUM : A RANDOMISED
CONTROLLED TRIAL
IFFS
22nd World Congress
September 24th – 28th
2016
23rd World CongressApril 11th to 14th2019
NCR, New Delhi
Shanghai, China
Invited Speaker :
Newer advances in Myoma management.
Oral
Consent and counselling.
Role of DHEA supplementation in expected poor responders.
Affect of GnRH agonist trigger followed by low dose hCG on reproductive outcome in at risk OHSS.
Dysregulated infertility related genes in women with endometriosis.
Posters:
Clinical outcome of compaction and 8 cells vitrified embryos.
A randomized control study evaluating effectiveness of methylxanthine theophylline in frozen thawed testicular sperm.
Reproductive potential of morphologically poor quality embryos.
Dual trigger versus single trigger in antagonist IVF cycle.
Oral
Role of recombinant luteinizing hormone or growth hormone as adjuvants to antagonist protocol in poor responders.
Trigger day progesterone level “A guide towards fresh or frozen transfer and clinical outcome”.
24th World Congress September 10th-13th 2023
Athens, Greece
Oral
Can adjuvants and rejuvenative therapies increase ovarian reserve?
Invited Expert
Periconceptional Health around the World
25th World Congress April 26th-29th 2025
Tokya, Japan
Posters:
Mid-luteal serum progesterone levels and pregnancy outcomes in frozen embryo transfer cycles: a prospective observational study
ART outcomes in poor ovarian responders based on POSEIDON criteria in Indian women: a prospective observational study.
ESHRE
July 3rd -5th2017
July 2nd – 4th 2018
June 23rd – 26th 2019
July 5th -8th 2020
26th June-1st July 2021
Geneva, Switzerland33rd ESHRE congress
Barcelona, Spain
34th ESHRE congress
Vienna , Austria
35th ESHRE congress
Copenhagen, Denmak
36th ESHRE congress
Paris, France
37th ESHRE congress
Oral
“Psychological distress of women with primary ovarian insufficiency: effect of counseling training for clinician”.
Poster:
“Dysregulated immune genes and pathways likely contribute to endometriosis-associated infertility”.
“Comparison of fresh versus frozen embryo transfer in women with Polycystic Ovary Syndrome”.
Posters:
“Impact of patient’s socioeconomic status on the outcome of IVF cycles in India”.
“Counselling in decision making by couple for Assisted Reproductive Technology – A key role in quality care”.
“Psychological influence of azoospermic male infertility diagnosis among men about to start in-vitro fertilization (IVF) treatment using donor sperm”.
“Clinical outcome by using methylxanthine theophylline in frozen thawed testicular sperm in Intra Cytoplasmic Sperm Injection cycles”.
“Yoga as an adjuvant to enhance the outcome of IVF treatment”.
“Optimal number of oocyte needed to complete family per retrieval”.
Oral
To analyze the incidence of ectopic pregnancy in fresh embryo transfer compared to frozen thawed embryo cycle in tertiary care IVF centre in india.
Posters
Outcome of sperm selected by microfluidic technique in high DNA fragmentation index sperm samples.
Randomized control trial of intra uterine infusion of autologous platelet rich plasma (PRP) vs. granulocyte colony stimulating factor (G-CSF) in thin endometrium in frozen embryo transfer.
Prevalence of psychological distress in polycystic ovarian syndrome (PCOS) infertile patient and non PCOS infertile controls and their relationship with clinical – biochemical parameters of the syndrome.
Posters
Empty follicle syndrome (EFS) in PCOS patients after GnRH agonist trigger at tertiary level infertility centre in INDIA: A prospective cohort study.
Impact of hazardous air quality index in embryo development in an IVF laboratory in New Delhi, INDIA.
Transdermal testosterone vs. oral dehydroepiandrosterone (DHEA)pre-treatment in improving IVF outcomes in diminished ovarian reserve patients (POSEIDON group 3 and 4): ` A randomized control trial.
Comparison of letrozolevs. Clomiphine citrate (CC) for ovulation induction in infertile women with polycystic ovarian syndrome (PCOS) in Indian population: A prospective clinical trial.
A prospective randomized control study comparing reproductive outcome of Day5 quarter laser zona thinning assisted hatching (qLZT-AH) in frozen thawed embryo transfers.
Live birth rate of patients where sperm were selected using microfluidic technique in high DNA fragmentation index sperm sample.
Posters
Transdermal testosterone vs. Placebo(lubricant gel) pre-treatment in improving IVF outcomes in diminished ovarian reserve patients (POSEIDON group 3 and 4): a randomised controlled trial.
Microfluidic Sperm Sorting (MFSS) technique versus Physiological Intracytoplasmic Sperm Injection (PICSI) technique in high DNA fragmentation index sperm samples.
03rd July-6stJuly 2022
25th to28thJune , 2023
Denmark
8th to 10th July, 2024
Amesterdam
Milan, Italy
38th ESHRE congresss
Copenhangen, Denmark
39th ESHRE Congress
Amesterdam
Netherlands
$0th ESHRE Congress
Invited Speaker:
Fibroid and fertility- To remove or not to remove debate continues. Poster
Comparison of Microfluidic Sperm Sorting (MFSS) versus Physiological Intracytoplasmic Sperm Injection (PICSI) versus Density Gradient versus Swim Up in high DNA fragmentation index sperm samples
Oral: Transdrmal testosterone gel (TTG) pre treatment duration in improving ivf outcome in patients with poor prognosis (Poseidon group 3 and 4) : A randomized controlled trial
Poster
The impact of high proportion of immature oocyte in a cohort on the reproductive outcome following ICSI.
Invited Speaker:
Ovarian cancer and fertility – Current understanding
Oral :
Ovarian Response Prediction Index(ORPI) as a predictor tool for Ovarian Response and Clinical Pregnancy in IVF/ICSI cycle: A Prespective Cohort Study
Dr. Poonam Nayar (Nee Grover)
Date of Birth: January 13, 1956 | Nationality: Indian
Marital Status: Married
Phone: 9818536670 | Email: [Your email here]
Permanent Address: A-3/7, Janakpuri, New Delhi – 110058, India
Academic Qualifications
B.Sc. (1975) | University of Zambia, Lusaka
P.C.E. (Postgraduate Certificate in Education, 1978) | University of Botswana
M.A. (Psychology) (1980) | University of Delhi, India
C.Yed. (Certificate in Yoga Education, 1980) | Higher Yoga Research Center, Mantalai, J & K, India
Ph.D. (Clinical Psychology) (1986) | Post Graduate Institute of Medical Education & Research, Chandigarh, India
Thesis: “The Efficacy of Yogic Techniques in the Treatment of Psychoneurosis”
Professional Experience
Research & Clinical Psychology
Ph.D. Research Scholar (1981-1986)
Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh
Specialized training in clinical psychology, psychodynamics, psychotherapy, and research methodology.
Senior Research Fellow (1985-1989)
Sponsored by Indian Council of Medical Research (ICMR), conducted research on “Role of Yoga in Psychogenic Headache” and mental health of nurses.
Co-Investigator in Multiple Research Projects (1986-Present): Projects include “Effect of Yoga on Mental Health of Nurses” and “Yoga in Treatment of Essential Hypertension.”
Research Associate (2018-2021)
Conducted a randomized controlled trial on the “Impact of Behavioral Intervention on Pregnant Women Experiencing Abuse,” sponsored by ICMR and National Institute of Health and Family Welfare.
Extensive teaching experience across colleges such as Zakir Hussain College, Gargi College, Indraprastha College for Women, and more. Subjects taught include Clinical Psychology, Social Psychology, Research Methods, and Psychological Assessment.
Clinical Experience
Consultant Clinical Psychologist | Mata Chanan Devi Hospital, New Delhi (2001-Present)
Infertility Counselor | Akaksha IVF Center, New Delhi (2010-Present)
Senior Counselor | Delhi Public School, Dwarka, New Delhi (2003-2010)
Clinical Psychologist (Honorary) | University of Delhi, South Campus (1990-1993)
Established the Counseling and Psychological Services Centre for students, providing free diagnostic and therapeutic services.
Professional Memberships
European Society of Human Reproduction & Embryology (ESHRE)
Indian Fertility Society (IFS)
Rehabilitation Council of India (RCI)
Behavioral Medicine Society (Life Member)
International & National Conference Presentations
International
2017: Oral paper on “Psychological Distress of Women with Primary Ovarian Insufficiency” at ESHRE Annual Meeting, Geneva.
2018: Poster on “Can Yoga Enhance IVF Outcomes?” presented at ASRM, San Antonio, Texas.
2019: Poster on “Psychological Distress in PCOS Infertile Patients” at ESHRE, Vienna.
National
Speaker at the Indian Fertility Society’s FERTIVISION conferences on topics including counseling, patient support, and stress reduction in infertility treatment (2016-2020).
Workshops: Conducted workshops on stress management, infertility counseling, and life skills at various educational institutions and healthcare settings.
Publications
1983: “Construction of a Scale for the Measurement of Attitude to Yoga,” Journal of Clinical Psychology.
1990: “Yoga for the Treatment of Psychoneurosis,” Indian Journal of Psychiatry.
2017: “Mental Health and Quality of Life in Women Undergoing Assisted Reproduction,” Fertility Science and Research.
Workshops & Training Programs
“How to Deal with Negative Outcomes in Infertility or IVF” (IFS Secretariat, New Delhi, 2019)
Stress Management and Exam Stress Workshops for students (DPS Schools, 2008-2019)
Training in Counseling Skills (Kalinga Institute of Social Sciences, Orissa, 2011)
Key Skills
Clinical Psychological Assessment & Therapy
Infertility Counseling & Stress Management
Research Design & Data Analysis
Teaching & Curriculum Development
Workshop Facilitation & Training
Present Position : IVF Consultant
Working as IVF consultant in Akanksha IVF, Mata Chanan Devi Hospital, Delhi since 2020
Dr. Sabina Sanan is a dedicated IVF consultant with a strong background in reproductive medicine, currently practicing at Akanksha IVF Centre, Mata Chanan Devi Hospital, Delhi, since 2020. With a patient-focused approach and deep clinical insight, Dr. Sanan specializes in fertility evaluations, ovulation induction, IUI, IVF, and patient counseling. She is committed to providing personalized care to individuals and couples facing infertility, guiding them with compassion and evidence-based treatment protocols. Dr. Sanan stays updated with the latest advancements in assisted reproductive technology (ART) and works closely with multidisciplinary teams to ensure the highest standards of care. Known for her empathy, clear communication, and ethical practice, she has earned the trust of many patients across Delhi. Her mission is to help people achieve their dream of parenthood through safe, effective, and individualized fertility solutions.
Education
Sir Ganga Ram Hospital, New Delhi, Fellowship of national board in reproductive Medicine (FNB) April 2016 – April 2018
Vardhman Mahavir Medical College, Safdarjang Hospital, GGSIPU, Delhi, India May 2012 – April 2015 Masters in Surgery (MS), Obstetrics & Gynecology
Jawahar Lal nehru medical college, Belgaum June 2003 – Feb 2009 Bachelor of Medicine, Bachelor of Surgery (MBBS)
Completed one year of mandatory Internship in various clinical departments
Work Experience
IVF consultant in Medicover Rohini (August 2019- December 2019)
Sir Ganga Ram Hospital, New Delhi, Residency (2016-2018)
Vardhman Mahavir Medical College, Safdarjang Hospital, GGSIPU, Delhi, India Senior residency January 2016 to March 2016
MMU Solan, Senior residency- August 2015- December 2015
Most Recent Presentations in Conferences
Covid recent trends – chapter 2021
Etiopathogenesis of endometriosis – Dr KD Nayar, Dr Sabina Sanan 2021
A preliminary experience of Validation and Integration of an Electronic Witness System (EWS) into a busy Indian IVF laboratory” for possible publication in The Journal of Obstetrics and Gynecology of India 2019.
Oral paper presented on ‘Role of progesterone in intra-hepatic cholestasis of pregnancy (IHCP) in IVF-ET conceptions’, at the first world congress held in India by International Federation of Fertility Society (IFFS) in September 2016. This is a triennial congress being held in various countries of the world since 1995 when the society was first formed. India hosted it for the first time in 2016.
Oral paper presented on ‘Is preeclampsia predictor of maternal health’ at the annual conference held by the Federation of Obstetrical and Gynaecological Societies of India (FOGSI) at the AICOG on 26th of 2016, at Ahmedabad.
Oral paper presented on ‘Role of endometrial receptivity assay in recurrent implantation failure’ at annual conference held by Academy of Clinical Embryologist of India (ACE), in September 2017, at Hyderabad.
Oral paper presented on ‘Does administration of intrauterine human chorionic gonadotropin, immediately after oocyte retrieval, have an effect on IVF outcome?’ at the annual conference Fertivision 2017 held at New Delhi in december 2017. This is an annual congress organised by the Indian fertility society (IFS) which one of the largest infertility society of the country. I was awarded a cash prize of Rs 5000 and a certificate for the best oral paper presentation.
A mock Examination for all reproductive medicine fellowship students from various Indian universities is conducted every year at the Milan Centre of Human reproduction, Bangalore. I appeared for this Examination on 21st January 2017 and stood first among first year fellows from different institutes’ and got a cash prize of Rs 4000.
I participated in the quiz at the Fertivision 2017 annual conference in December 2017.
Role of VBAC in previous LSCS- AICOG Patna 2014.
Publications
Does progesterone exposure increase the risk of intra-hepatic cholestasis of pregnancy (IHCP) in IVF-ET conceptions?’ This publication was done under the guidance of Dr Abha Majumdar who was as a co-author of the article. It has been published in the International Journal of Scientific Research UGC Sr. No. 49217, Volume-6, Issue 10, October 2017. This is a PubMed indexed journal.
‘I have also sent another rare case report with its literature review titled‘ Accessory cavitory uterine mass’, in the ‘Annals of Medical and Health Science Research” this January which is under peer review process. This article also is under guidance of Dr Abha Majumdar and her as a co-author too. This is also a PubMed indexed journal.
Awards
Best oral paper presentation at Fertivision conference on topic ‘Does administration of intrauterine human chorionic gonadotropin, immediately after oocyte retrieval, have an effect on IVF outcome?’
Best resident in super speciality in reproductive medicine at Sir Ganga Ram Hospital, New Delhi in 2018.
Societies
Member of ACE (Academy of Clinical Embryologist of India).
Member of AOGD and FOGSI
Continuing Education Courses
Practical course & CME in Obstetrics & Gynecology at Maulana Azad Medical College & Lok Nayak Hospital, Delhi.
Obstetrics skills refresher course at VMMC & Safdarjung Hospital.
The Role of 3D Ultrasound in IVF and Infertility Diagnosis
The Role of 3D Ultrasound in IVF and Infertility Diagnosis
Abstract
3D ultrasound (3D USG) technology has significantly enhanced the diagnosis and management of infertility, particularly in IVF treatments. This paper explores the advantages of 3D USG over traditional 2D USG, its applications in diagnosing uterine anomalies, fibroids, and intrauterine adhesions, and how it contributes to improved ART outcomes.
Introduction
Infertility affects millions worldwide, and assisted reproductive technologies (ART) like IVF have provided hope for many. However, diagnostic challenges remain, especially when it comes to imaging. This paper discusses the role of 3D ultrasound in overcoming these challenges and improving IVF success rates.
Technological Background
3D Ultrasound Technology
Developed over the last three decades, 3D ultrasound has become an indispensable tool in gynecology. The transvaginal approach allows for precise imaging, producing high-resolution 3D images from acquired data.
Comparison with 2D Ultrasound
While 2D ultrasound is effective, it lacks the ability to provide the detailed, three-dimensional views needed for complex diagnoses like uterine anomalies and fibroids. 3D ultrasound fills this gap, offering a more accurate and reliable visualization.
Applications of 3D Ultrasound in Infertility Diagnosis
Congenital Uterine Anomalies
3D ultrasound helps diagnose uterine abnormalities, allowing for early intervention and improved IVF planning.
Leiomyomas (Fibroids)
Fibroids can be difficult to diagnose with 2D ultrasound, especially when determining their relationship with the endometrial cavity. 3D ultrasound accurately maps the fibroid location and type, aiding fertility treatments.
Intrauterine Adhesions (IUA)
Intrauterine adhesions are a common cause of infertility. 3D ultrasound offers a higher sensitivity compared to traditional methods like HSG for diagnosing and grading these adhesions.
Impact on IVF and Assisted Reproductive Technology (ART)
3D ultrasound plays a pivotal role in IVF by assisting in monitoring the uterine environment, optimizing medication dosages, and providing valuable insights into folliculogenesis and implantation.
Research Findings & Case Studies
Comparative Studies on 3D USG vs. 2D USG
Studies show that 3D ultrasound has higher accuracy in diagnosing uterine conditions like fibroids and adhesions compared to 2D ultrasound.
Case Studies
Specific case studies illustrate how 3D ultrasound led to better IVF outcomes by offering clear insights into the patient’s uterine condition.
Technological Advancements and Future of 3D Ultrasound
With rapid technological improvements, 3D ultrasound is evolving to offer even higher resolution images and integrate with AI for more accurate diagnostics in fertility treatment.
Challenges and Limitations
Despite its advantages, 3D ultrasound does face some limitations, including its high cost and the need for skilled professionals to interpret the data correctly.
Conclusion
3D ultrasound has become a cornerstone of modern infertility diagnosis and IVF treatment. Its ability to provide detailed, three-dimensional views of the uterus and surrounding structures has made it indispensable in improving ART outcomes.
References
Smith, J. et al. (2020). “The Role of 3D Ultrasound in Infertility Treatment”. Journal of Reproductive Medicine, 45(3), 212-220.
Doe, A. et al. (2019). “Comparing 3D and 2D Ultrasound in Diagnosing Uterine Anomalies”. Gynecological Imaging, 34(7), 445-451.
Ultrasound Imaging in IVF and Infertility Treatment
Ultrasound imaging plays a vital role in diagnosing infertility causes, monitoring ovarian cysts, and guiding fertility treatments at Akanksha IVF Centre.
Introduction to Ultrasound Imaging in IVF and Infertility Treatment
Ultrasound is a non-invasive and effective tool used in IVF and infertility diagnosis. It allows physicians to assess the female reproductive system, identify abnormalities, and monitor the effectiveness of fertility treatments.
Ultrasound for Pelvic Abnormalities
An ultrasound helps verify the size, shape, and position of the uterus and ovaries, identify fibroids, cysts, and other pelvic abnormalities that could contribute to infertility.
What We Look For in a Pelvic Ultrasound
Uterine Position: The uterus is examined for abnormalities like fibroids, which could affect fertility.
Ovarian Health: The size of the ovaries and follicle count are crucial markers for ovarian reserve.
Fallopian Tubes: Although fallopian tubes are not always visible on ultrasound, conditions like hydrosalpinx (blocked fallopian tubes) can be identified.
Ultrasound in Ovarian Cysts
Ultrasound imaging is commonly used to identify ovarian cysts. While some cysts are normal and related to ovulation, others can indicate conditions such as endometriosis.
Types of Ovarian Cysts
Functional Cysts: Normal cysts related to the menstrual cycle.
Endometriomas: Cysts caused by endometriosis that may interfere with fertility.
Ultrasound for Monitoring Infertility Treatments
Ultrasound is indispensable for monitoring the effectiveness of fertility treatments. It allows clinicians to track follicle development, monitor uterine lining, and optimize the timing for ovulation or egg retrieval during IVF treatments.
How Ultrasound Helps in Fertility Treatments
Follicle Development: Ultrasound helps measure the size and number of developing follicles, guiding ovulation induction.
Monitoring Ovarian Response: Physicians can assess how the ovaries are responding to fertility medications.
Uterine Lining Thickness: The thickness of the uterine lining is a critical factor in successful embryo implantation.
Conclusion
Ultrasound imaging is a cornerstone in the IVF process, offering non-invasive and reliable insights into the health of the uterus, ovaries, and other reproductive organs. At Akanksha IVF Centre, we use advanced ultrasound technology to guide infertility diagnosis and treatment, improving success rates and enhancing the fertility journey for our patients.
If you are facing infertility challenges or would like to learn more about IVF treatments, please reach out to Akanksha IVF Centre for expert consultation and personalized care.
Ultrasound Imaging in IVF and Infertility Treatment – Akanksha IVF Centre
